Page 255 - Detection News Today

The first phase of a study involving medical detection dogs found that they may be able to sniff out covid-19 in peoples clothing and masks. now, this test group included labrador, golden retriever, and cocker spaniel breeds and professor james logan led the study. he heads the department of disease control at the london school of hygiene and tropical medicine. professor logan, its great to have you with us. how does this training work? >> well, thank you very much for having me. so, the trainin...

town and city centres To prevent contamination of the sample locations, personnel undertaking the survey will be fully suited in protective clothing. The sampling techniques used are non-invasive, non-toxic and leave no residue. The collected samples will be analysed at the Dstl Forensic Explosives Laboratory (FEL), an internationally recognised leading authority in the detection and identification of explosive traces. FEL staff attend scenes of crime relating to explosives, and painstakingly a...

Photo Credit: IANS IANSLive Chennai, May 22 (IANS) With the 35 years old Rs 400 crore medical syringes brand Dispovan and the Defence Research Development Organisations (DRDO) Dipcovan - coronavirus antibody detection kit - sounding similar, Hindustan Syringes & Medical Devices Ltd will request the defence lab to have a different brand name, said a top company official. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights R...

Photo Credit: IANS IANSLive New York, May 22 (IANS) A team of researchers has developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 22-May-2021

Photo Credit: IANS IANSLive New York, May 22 (IANS) A team of researchers has developed, at the laboratory level, a prototype of a new biosensor to help detect breast cancer in its earliest stages. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 22-May-2021

Sniffing dogs at the south beach wine and food festival. this is her trainer, john mills with her here. lets go over and show you how it goes. so, as people make their way to come into the festival, you can see the crowd starting to come. one of the events starting this afternoon. they are greeted by dogs like beta. they are detecting one thing, one thing only, covid-19. they kind of sniff around the feet especially. they are looking for any sort of covid-19 volatiles that can be picked up on su...

May 21 2021 Contamination of food is a global problem, whether it is done intentionally for profit or accidentally through negligence, the end result is the same - consumers pay the price. The problem of food contamination can be addressed with complex analytical laboratory techniques such as GC-MS and HPLC, but time, skill, and cost requirements limit their usage to the confines of well-equipped laboratories. Surface Enhanced Raman Scattering (SERS) - an extension of Raman spec...

The kit has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) of DRDO.

Narcotics Push into South Texas Border Area amid 20-Year High in Illegal Migration by RANDY CLARK 19 May 2021 The Rio Grande Valley Sector already

Department of Health ATAGI met on Wednesday 19 May 2021 to review the latest developments relating to the AstraZeneca COVID-19 vaccine and Thrombosis and Thrombocytopenia Syndrome (TTS) cases in Australia and overseas. ATAGI considered updated estimates of risk of TTS by age group in Australia and note that 20 cases have been confirmed and a further 3 are considered probable in around 1.5 million doses of COVID-19 Vaccine AstraZeneca given up to 5 May 2021. Although estimates of risk based on s...